News

CILcare at NDD Summit on July 30 – August 1, 2018

CILcare at NDD Summit on July 30 – August 1, 2018

Meet Dr. Gaëlle NAERT and Dr. Wahid AWAD at the Neuropsychiatric Drug Development Summit in Boston to know more about the link between hearing & neurodegenerative disorders ! About NDD Summit: The inaugural Neuropsychiatric Drug Development...

How is cardiovascular disease associated with hearing?

How is cardiovascular disease associated with hearing?

Treating underlying cardiovascular disease may prevent or slow the progression of hearing loss, and conversely, hearing loss may suggest underlying cardiovascular disease.  Discover a recent publication describing the association between cardiavascular disease and...

CILcare will be attending the 6th edition of AFSSI Connexions

CILcare will be attending the 6th edition of AFSSI Connexions

Meet CILcare's CEO Celia Belline at the Annual meeting of preclinical research in Marseille Round table: International Perspective July 2, 2018 | 4 PM Pitch session #3 July 3, 2018 | 3:30 PM The Annual meetings of preclinical research: The AFSSI organizes in...

CILcare and Amylgen partner against Alzheimer’s disease

CILcare and Amylgen partner against Alzheimer’s disease

Age-related disorders, CILcare and Amylgen partner to propose unique preclinical models to assess the effects of health solutions on hearing and cognitive functions ! It is established that hearing loss is one of the three major risk factors for dementia and is...

CILcare will exhibit at the WPC 2018

CILcare will exhibit at the WPC 2018

Please meet Marie-Pierre Pasdelou, PhD., CILcare Inc Director and Michael Naimark, Director of Business Development CBSET, to learn more about their article in stem cell and regenerative therapies for hearing loss:...

CILcare will be attending the BOS 2018

CILcare will be attending the BOS 2018

CILcare will be attending the Biotech Outsourcing Strategies Event 2018 taking place in Basel Meet Wahid AWAD, Ph.D. and attend his presentation on June 19th, 2018 from 11 to 12 AM to discover the topic: "assessing compound efficacy in an age-related hearing loss...

BIO 2018: Making hearing a priority

BIO 2018: Making hearing a priority

The pitch of CILcare's CEO Celia Belline at BIO International Convention 2018 discusses the development of new treatments for hearing disorders. Due to the significant increase in hearing loss, specifically in the younger population, hearing has become a real public...